Abstract
Objective
ADAMTS13 cleaves von Willebrand factor (VWF), thereby modulating thrombosis and inflammation. Low plasma ADAMTS13 activity is associated with cardiovascular events including myocardial and cerebral infarction. Here, we investigated the role of ADAMTS13 in the development of early atherosclerosis in a murine model.
Methods and Results
ApoE−/− and Adamts13−/−ApoE−/− mice were fed with a high fat Western diet for 12 weeks. Atherosclerotic lesions in the aorta and aortic roots were quantified after staining. Leukocyte rolling and adhesion onto cremaster venules after oxidative injury were determined by intravital microscopy. While plasma cholesterol levels were largely similar in both groups, the extent of atherosclerotic lesions in the aorta en face and in the aortic roots in the Adamts13−/−ApoE−/− mice increased ~5.5 fold (p=0.0017) and ~6.1 fold (p=0.0037), respectively. Also, the ratio of plasma high to low molecular weight VWF multimers increased ~3 fold. The leukocyte rolling velocities were significantly reduced (p<0.001) with an increased number of leukocyte rolling (p=0.0026) and macrophage infiltration into the atherosclerotic lesions in the Adamts13−/−ApoE−/− mice.
Conclusions
Our results suggest that ADAMTS13 plays a critical role in modulating the development of early atherosclerosis, likely through proteolytic cleavage of ultra large VWF multimers, thereby inhibiting platelet deposition and inflammation.
Keywords: von Willebrand factor cleaving protease, inflammation, and animal model
Introduction
ADAMTS13, a member of ADisintegrin And Metalloprotease with ThromboSpondin type 1 repeats family, is primarily synthesized in the liver 1, 2. Plasma ADAMTS13 metalloprotease cleaves a blood adhesion protein von Willebrand factor (VWF) at the Tyr1605-Met1606 bond 3, 4. VWF is synthesized in all vascular endothelial beds and constitutively secreted or stored in Weibel-Palade bodies of the endothelium 5. Upon stimulation by a variety of agonists such as epinephrine 6, ADP 7, and thrombin 8 or desmopressin 9, the stored VWF multimers are released. The newly released ultra large (UL) VWF forms “string-like” polymers, which remain anchored on endothelial cell membrane. The cell bound VWF polymers are highly sensitive to proteolysis by plasma ADAMTS13 metalloprotease 10–12. Once being released into circulation, VWF polymers alter their conformations, becoming resistant to ADAMTS13 until they are unfolded by arterial shear stress 13, 14. If this process is compromised, ultra large VWF polymers bind circulating platelets spontaneously and cause exaggerated platelet aggregation and disseminated thromboses in small arteries and capillaries, exemplified by thrombotic thrombocytopenic purpura (TTP), a potentially fatal syndrome 14–16.
ADAMTS13 and VWF play an opposite role in thrombosis and systemic inflammation. Adamts13−/− mice exhibit an increase in leukocyte rolling, adhesion, and extravasation in a murine model of acute inflammation 17. Epidemiological studies also show an association between the reduced ratio of plasma ADAMTS13 activity to VWF antigen and pathological conditions such as chronic inflammation 18 and cardiovascular 19 or cerebral vascular events 20.
Here, we demonstrate that genetic ablation of the Adamts13 gene in the ApoE-null mice (Adamts13−/− ApoE−/−) fed a high fat Western diet dramatically accelerates the development of early atherosclerosis. Also, an increased leukocyte rolling over endothelium after oxidative injury and increased macrophage infiltration into atherosclerotic lesions may underlie the pathogenesis of atherosclerosis in Adamts13−/−ApoE−/− mice. Together, our findings demonstrate the critical role of ADAMTS13 proteolysis in modulating early atherosclerosis in genetically susceptible mice.
Methods
Animals and diet
All animal studies were approved by Institutional Animal Care and Use Committees (IACUC) at The Children’s Hospital of Philadelphia and The University of Pennsylvania Perelman School of Medicine. ApoE−/− mice (C57BL/6J strain) were purchased from the Jackson Laboratory (Bar Harbor, Maine). Adamts13−/− mice (C57BL/6/129 strain) were kindly provided by Dr. David Ginsburg (Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan). ApoE−/− and Adamts13−/− mice were bred for more than four times to generate Adamts13−/− ApoE−/− mice. Mice at the age of 6 weeks were fed with a high fat Western diet from Harlan Laboratories (Madison, Wisconsin) consisting of 21.2% fat and 0.2% cholesterol for a total of 12 weeks.
Blood collection
Whole blood (200 μl) was collected via retro orbital sinus plexus from mice after 4 hours of fasting for plasma lipid analyses. The blood was anti-coagulated (9:1, vol:vol) with 3.9% sodium citrate. Plasma was obtained after centrifugation for 10 min at 10,000 rpm in a microcentrifuge and stored in aliquots at −80 °C.
En face Oil red staining of atherosclerotic lesions in aorta
Mice were euthanized by intra-peritoneal injection of a lethal dose of nembutal. The entire aorta and heart were surgically isolated under a dissecting microscope and fixed overnight with 10% neutrally buffered formalin. The extent of atherosclerotic lesions en face in the aorta was determined by Oil Red O staining 21. All images were obtained under a light microscope with magnifications (100x and 200x) and quantified by ImageJ analysis software.
Histological examination of atherosclerotic lesions in aortic roots
The heart was fixed overnight with 10% neutral buffered formalin and embedded with tissue freezing medium (Ted Pella Inc, Redding California). The heart was then sectioned (6 μm, interspaced by 80 μm) using a cryostat. Twelve tissue sections from each heart were placed on each slide and stained with hematoxylin and eosin in the histology core facility at the University of Pennsylvania. Digital images were obtained for each section using a Nikon ECLIPSE-80i microscope equipped with a Nikon digital camera DXM1200. The areas of atherosclerotic lesions in all sections of entire aortic roots were analyzed with ImageJ software in a blind fashion.
Plasma VWF multimer analysis
Citrated mouse plasma (1.0 μL) was denatured by heating at 60°C for 20 minutes in 70 mM Tris-HCl, pH 6.5 containing 2.4% SDS, 4% urea, and 4 mM EDTA. The denatured sample was fractionated on a 1.0% SeaKem HGT agarose (Cambrex, East Rutherford, New Jersey) mini-gel by electrophoresis at 15 mA for 2.5 hours. After being transferred onto a nitrocellulose membrane (Bio-Rad, Hercules, California), the membrane was blocked by TBSc (20 mM Tris-HCl, pH 7.5,150 mM NaCl, and 1% casein) for 30 minutes. The membrane was incubated overnight at 4°C with rabbit anti-VWF IgG (DAKO, Carpinteria, California) in TBSc (1:1,500), followed by an incubation with IRDyeCW800-labeled goat anti–rabbit IgG (LI-COR, Lincoln, Nebraska) in TBSc (1:12,500) for 1 hour. The fluorescent signal was obtained using an Odyssey imaging system (LI-COR, Lincoln, Nebraska).
Lipid Analysis
Plasma total cholesterol, high-density lipoprotein (HDL) cholesterol, and triglyceride levels were determined on a chemistry analyzer (Roche Diagnostics Systems, Indianapolis, Indiana) using commercially available reagents (Wako Pure Chemical Industries and Trinity Biotech, Jamestown, New York).
Leukocyte rolling and velocity rate
Mice were anesthetized with an intra peritoneal injection of Nembutal. Cremaster vessels were exposed and injured by topical application of a filter paper soaked with 2.5% FeCl3 for 10 sec. Rhodamine 6G (Sigma, St. Louis, Missouri) (1 μg/g body weight diluted with 100 μl of PBS) was injected via retro orbital sinus plexus to label leukocytes and platelets. The leukocytes rolling over the injured vessels were recorded in real time under an inverted fluorescent microscope (100x) equipped with a high-speed digital camera (Olympics, Center Valley, Pennsylvania). All movies were recorded using the NIS Elements software from Nikon Instruments, Inc (Melville, New York).
The number of leukocyte rolling and rolling velocity (μm/second) were determined offline using the NIS Elements image analysis program. The number of leukocytes rolling over the injured vessel was determined at 6 different sites in each mouse for a total 6 mice in each group. The velocity was determined by the equation (1):
(1) |
Here, v refers to the velocity (μm/second).
The cumulative frequencies as a function of various velocities were fit into a sigmoidal curve using the GraphPad software (La Jolla, California).
Immunohistochemical staining of macrophages
After being embedded into tissue freezing medium, formalin-fixed aortic tissues were sectioned (6 μm) using a cryostat. Tissue sections were rinsed with PBS and treated with 0.1 M sodium citrate (pH 6.0) for 5 min in a pressure cooker to retrieve antigen. After being blocked with avidin-biotin blocking solution (Vector, Burlingame, California), the tissue sections were incubated overnight at 4°C with rat anti-mouse CD107b (Mac3) (BD Pargmingen, San Jose, California) (1:100) followed by incubation for one hour with ImmPRESS anti-rat IgG (Vector). The tissue sections were counterstained with hematoxylin and mounted with Permount medium purchased from Fisher Scientific (Pittsburgh, Pennsylvania). Digital images were obtained under a Nikon Eclipse 80i fluorescent microscope.
Statistical analysis
The means and standard deviation or standard error of the means (SEM) were determined. The difference of the continuous variances between two groups was determined by the two-tailed Student’s t-test. One-way ANOVA analysis of the variants was determined with Prism5 GraphPad Software for the significant differences among various groups.
Results
Adamts13−/−ApoE−/− mice show an increased formation of atherosclerotic lesions in aorta and aortic roots
Epidemiological studies suggest that a reduced ratio of plasma ADAMTS13 activity to plasma VWF antigen is a risk factor for development of cardiovascular diseases, particularly myocardial infarction 19, 22, 23 and ischemic stroke 20, 24. However, the causative role of the reduced plasma ADAMTS13 activity and elevated plasma VWF has not been fully established. To address this question, Adamts13−/− ApoE−/− and ApoE−/− mice at the age of 6 weeks were fed a high fat Western diet for 12 weeks and then sacrificed. The entire aorta was isolated, fixed, and stained en face with oil red O. The results showed substantially greater lesion development in Adamts13−/−ApoE−/− mice (Fig. 1B) as compared with that in ApoE−/− mice (Fig. 1A). Histological examination after hematoxylin and eosin (H&E) staining confirmed the atherosclerotic lesion in both groups of mice (Fig. 1C and 1D). Image analyses demonstrated that the relative surface areas of atherosclerotic plaques in the aortas of the Adamts13−/− ApoE−/− mice increased ~5.5 fold (p=0.00165) (Fig. 1E). Moreover, the hearts were harvested, embedded, and cryosectioned. The heart sections were stained with H&E, revealing substantially greater lesion development in the Adamts13−/−ApoE−/− mice (Fig. 2B) than in the ApoE−/ − mice (Fig. 2A). Image analyses further showed that the extent of atherosclerotic lesions in the aortic roots in the Adamts13−/− ApoE−/− mice increased ~6.1 fold (Fig. 2C) (p=0.00367). These results demonstrate that ADAMTS13 metalloprotease may play a critical role protecting against the formation of early atherosclerosis in genetically susceptible mice.
Ultra large VWF multimers are present in Adamts13−/−ApoE−/− mice
Mice deficient for plasma ADAMTS13 activity show an accumulation of ultra large VWF multimers on stimulated or damaged endothelial cells 25 and in plasma 26, 27. To determine whether ApoE deficiency plus being fed with a Western diet further impair VWF homeostasis, we determined plasma VWF multimer distribution by agarose gel electrophoresis as described in the Methods. The ratio of ultra large VWF to low molecular weight VWF multimers in the Adamts13−/− ApoE−/− increased by ~3 fold compared with that in the ApoE−/− or wild-type mice (Fig. 3A and 3B). However, the ratio of ultra large VWF to low molecular weight VWF in these mice was not significantly different from that in the Adamts13−/− mice (Fig. 3). These results demonstrate that genetic ablation of Adamts13 gene results in an accumulation of ultra large VWF multimers in plasma, but the additional deletion of the ApoE plus a high fat diet has no further deleterious effect on VWF homeostasis.
Adamts13 deficiency has little effect on plasma cholesterol metabolism
To rule out the potential effect of Adamts13 proteolysis on cholesterol metabolism, we determined plasma total cholesterol, HDLs, and triglycerides in various groups of mice after being fed a high fat Western diet for 12 weeks. The levels of total cholesterol, non-HDL cholesterol, and triglycerides did not significantly differ between Adamts13−/−ApoE−/− mice and ApoE−/− mice, while the levels of HDL cholesterol in Adamts13−/−ApoE−/− mice (95.3 ± 39.0 mg/dl) were slightly higher than in ApoE−/− mice (65.6 ± 17.4 mg/dl). The difference was statistically highly significant (p=0.02) (Table 1). The similar lipid profiles in both groups except for an increased level of HDL cholesterol in Adamts13−/− ApoE−/ − mice suggest that the increase of atherosclerotic plagues is not the result of impaired cholesterol metabolism, but the direct effect of lacking ADAMTS13 metalloprotease.
Table 1.
ApoE−/− (mg/dl)(n=13) | A13−/−ApoE−/−(mg/dl)(n=13) | p values | |
---|---|---|---|
Total Cholesterol | 1,204.4± 397.7 | 1,448.1 ± 536.6 | 0.20 |
HDL | 65.6 ± 17.4 | 95.3 ± 39.0 | 0.02* |
Triglyceride | 123.4 ± 65.6 | 118.4 ± 62.3 | 0.84 |
Non-HDL | 1,138.7 ± 393.3 | 1,352.8 ± 518.6 | 0.25 |
A13−/−, Adamts13−/−; p values were obtained by Student t-test (two-tailed and two samples with equal variance); n, number of mice in each group;
p value<0.05 is considered to be statistically significant.
Increased leukocyte rolling, adhesion, and infiltration in the Adamts13−/− ApoE−/ − mice
VWF is the only known substrate of ADAMTS13 identified to date. Previous studies show that Adamts13−/− mice have enhanced systemic inflammatory responses, exhibiting increased leukocyte rolling, adhesion and extravasation, which depends on VWF 17. By intravital microscopy, we showed that the number of fluorescent rhodamine 6G-labeled leukocytes rolling over or adhered to the injured venules was significantly increased in Adamts13−/−ApoE−/− mice (44.1 ± 1.5, means ± SEM, n=6) compared with that in ApoE−/− mice (24.7 ± 0.8, means ± SEM, n=6) (p=0.0026) (Fig. 4). Consistently, the velocity of leukocyte rolling in the same vessels in the Adamts13−/−ApoE−/− mice was dramatically reduced (p<0.001) (Fig. 4). These findings were mirrored by the increased number of infiltrated macrophages (Mac-3 positive) in the atherosclerotic plagues in the Adamts13−/−ApoE−/− mice (Fig. 5). Together, these results indicate that ADAMTS13 metalloprotease plays an important role in attenuating systemic inflammatory responses.
Discussion
In the present study, we demonstrate that Adamts13−/− ApoE−/− mice develop more extensive and larger atherosclerotic plaques in the branch points of the aorta (Fig. 1) and the aortic roots (Fig. 2) after 12 weeks on a high fat Western diet. These results suggest that ADAMTS13 metalloprotease protects against the development of early atherosclerosis in a genetically susceptible animal. Interestingly, the increase in atherosclerotic lesions in both the aorta and aortic arches in the Adamts13−/− ApoE−/− mice appears to be much greater than that recently reported 28. This discrepancy is not simply caused by the relatively low volume of atherosclerotic lesions in our control mice, as the area of atherosclerotic lesions in ApoE−/− mice (Fig. 1 and Fig. 2) from both studies is comparable 28. While total cholesterols, triglycerides, and LDLs are not significantly altered, plasma HDL levels are significantly increased in Adamts13−/− ApoE−/− mice in this study (p=0.02). The mechanism underlying the HDL elevation in Adamts13−/− ApoE−/− mice is yet to be determined.
It is also not clear how ADAMTS13 metalloprotease protects against the formation of early atherosclerosis in ApoE−/− mice. We hypothesize that the deficiency of plasma ADAMTS13 activity results in an accumulation of ultra large VWF multimers on endothelial cell surfaces and in plasma, which enhances both platelet aggregation and systemic inflammation. This hypothesis is based on a number of published studies showing the accumulation of ultra large VWF strings on endothelial cells upon injury in Adamts13−/− mice 17, 25, 29. An infusion of recombinant ADAMTS13 rapidly eliminates the cell bound VWF strings in vivo 25, 29. We showed that the ratio of plasma ultra large VWF to low molecular weight VWF multimers in either Adamts13−/− mice 26 or Adamts13−/− ApoE−/− mice were dramatically increased (Fig. 3). Both ultra large VWF multimers and adherent platelets have been shown to promote systemic and local inflammation, and play a role in the development of atherosclerosis 30, 31. Consistent with this notion, the number of leukocytes rolled over the injured vessels increases ~2 fold, corresponding with the significant reduction in leukocyte rolling velocity (Fig. 4), which results in increased macrophage infiltration into the atherosclerotic lesions (Fig. 5). Similar findings have recently been reported at the site of atherosclerotic plagues in the carotid artery32. Together, these data suggest that an increased inflammatory response in Adamts13−/− ApoE−/− mice may contribute to the accelerated formation of atherosclerosis.
It remains to be determined, however, whether ADAMTS13 has a direct effect against atherosclerosis or merely functions to reduce the adhesiveness of ultra large VWF multimers, thereby an anti-athero effect is indirect. A previous study demonstrated a ~40% reduction of atherosclerotic lesion area in the vwf−/− and LDLR−/− mice compared with the LDLR−/− mice after 8 weeks on a high fat diet 33. Furthermore, an inhibition of platelet adhesion to VWF with a monoclonal antibody against GP1bα also reduced leukocyte adhesion and formation of atherosclerotic lesions in the ApoE−/− mice 34. These results support that VWF, platelets, and leukocytes all play a role in the development of early atherosclerosis.
The interaction between VWF and leukocytes is largely mediated by binding of endothelial VWF to leukocyte P-selectin glycoprotein ligand-1 (PSGL-1) 35, 36, P-selectin, and L-selectin 37, 38. PSGL-1−/− mice exhibit selective impairment in leukocyte recruitment into the atherosclerotic arterial wall 39. Inhibition of P-selectin completely abrogates leukocyte rolling in Adamts13−/− mice, suggesting that P-selectin is required for initiating leukocyte rolling even in the presence of endothelial VWF strings 17.
In conclusion, we demonstrate that the genetic ablation of the Adamts13 gene in ApoE null mice fed a high diet results in an accelerated formation of early atherosclerosis. We hypothesize that the underlying mechanism may be associated with increased systemic and local inflammation as reflected by increased initial leukocyte rolling, adhesion, and infiltration at the site of injury. Our findings provide further evidence demonstrating the critical role of ADAMTS13 metalloprotease in attenuating the formation of early atherosclerotic plagues in a genetically susceptible individual.
Supplementary Material
Acknowledgments
The authors thank Dr. David Ginsburg from The Department of Genetics, University of Michigan, Ann Arbor, for providing Adamts13−/− mice.
Sources of Funding
This study is partially supported by grants from the American Heart Association Established Investigator Award (AHA-0940100N) and National Institute of Health (P01HL074124, project 3).
Footnotes
Disclosures
The authors have no relevant conflict of interest to disclose.
Reference List
- 1.Uemura M, Tatsumi K, Matsumoto M, Fujimoto M, Matsuyama T, Ishikawa M, Iwamoto TA, Mori T, Wanaka A, Fukui H, Fujimura Y. Localization of ADAMTS13 to the stellate cells of human liver. Blood. 2005;106:922–924. doi: 10.1182/blood-2005-01-0152. [DOI] [PubMed] [Google Scholar]
- 2.Zheng XL, Chung D, Takayama T, Majerus E, Sadler J, Fujikawa K. Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem. 2001;276:41059–41063. doi: 10.1074/jbc.C100515200. [DOI] [PubMed] [Google Scholar]
- 3.Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood. 1996;87:42354244. [PubMed] [Google Scholar]
- 4.Zheng XL, Majerus E, Sadler J. ADAMTS13 and TTP. Curr Opin Hematol. 2002;9:389–394. doi: 10.1097/00062752-200209000-00001. [DOI] [PubMed] [Google Scholar]
- 5.Wagner DD, Marder VJ. Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization. J Cell Biol. 1984;99:2123–2130. doi: 10.1083/jcb.99.6.2123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Goto S, Ikeda Y, Murata M, Handa M, Takahashi E, Yoshioka A, Fujimura Y, Fukuyama M, Handa S, Ogawa S. Epinephrine augments von Willebrand factor-dependent shear-induced platelet aggregation. Circulation. 1992;86:1859–1863. doi: 10.1161/01.cir.86.6.1859. [DOI] [PubMed] [Google Scholar]
- 7.Palmer DS, Aye MT, Ganz PR, Halpenny M, Hashemi S. Adenosine nucleotides and serotonin stimulate von Willebrand factor release from cultured human endothelial cells. Thromb Haemost. 1994;72:132–139. [PubMed] [Google Scholar]
- 8.Mayadas T, Wagner DD, Simpson PJ. von Willebrand factor biosynthesis and partitioning between constitutive and regulated pathways of secretion after thrombin stimulation. Blood. 1989;73:706–711. [PubMed] [Google Scholar]
- 9.Kaufmann JE, Oksche A, Wollheim CB, Gunther G, Rosenthal W, Vischer UM. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. J Clin Invest. 2000;106:107–116. doi: 10.1172/JCI9516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Dong JF, Moake JL, Nolasco L, Bernardo A, Arceneaux W, Shrimpton CN, Schade AJ, McIntire LV, Fujikawa K, Lopez JA. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood. 2002;100:4033–4039. doi: 10.1182/blood-2002-05-1401. [DOI] [PubMed] [Google Scholar]
- 11.Dong JF, Moake JL, Bernardo A, Fujikawa K, Ball C, Nolasco L, Lopez JA, Cruz MA. ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor. J Biol Chem. 2003;278:29633–19639. doi: 10.1074/jbc.M301385200. [DOI] [PubMed] [Google Scholar]
- 12.Dong JF. Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions. J Thromb Haemost. 2005;3:1710–1716. doi: 10.1111/j.1538-7836.2005.01360.x. [DOI] [PubMed] [Google Scholar]
- 13.Tsai HM, Sussman I, Nagel RL. Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood. 1994;83:2171–2179. [PubMed] [Google Scholar]
- 14.Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998;339:1585–1594. doi: 10.1056/NEJM199811263392203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002;347:589–600. doi: 10.1056/NEJMra020528. [DOI] [PubMed] [Google Scholar]
- 16.Zheng XL, Pallera AM, Goodnough LT, Sadler JE, Blinder MA. Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab. Ann Intern Med. 2003;138:105–108. doi: 10.7326/0003-4819-138-2-200301210-00011. [DOI] [PubMed] [Google Scholar]
- 17.Chauhan AK, Kisucka J, Brill A, Walsh MT, Scheiflinger F, Wagner DD. ADAMTS13: a new link between thrombosis and inflammation. J Exp Med. 2008;205:2065–2074. doi: 10.1084/jem.20080130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Reiter R, Varadi K, Turecek P, Jilma B, Knobl P. Changes in ADAMTS13 (von- Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation. Thromb Haemost. 2005;93:554–558. doi: 10.1160/TH04-08-0467. [DOI] [PubMed] [Google Scholar]
- 19.Matsukawa M, Kaikita K, Soejima K, Fuchigami S, Nakamura Y, Honda T, Tsujita K, Nagayoshi Y, Kojima S, Shimomura H, Sugiyama S, Fujimoto K, Yoshimura M, Nakagaki T, Ogawa H. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction. Am J Cardiol. 2007;100:758–763. doi: 10.1016/j.amjcard.2007.03.095. [DOI] [PubMed] [Google Scholar]
- 20.Bongers TN, De Maat MP, van Goor ML, Bhagwanbali V, van Vliet HH, Gomez Garcia EB, Dippel DW, Leebeek FW. High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability. Stroke. 2006;37:2672–2677. doi: 10.1161/01.STR.0000244767.39962.f7. [DOI] [PubMed] [Google Scholar]
- 21.Tangirala RK, Tsukamoto K, Chun SH, Usher D, Pure E, Rader DJ. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation. 1999;100:1816–1822. doi: 10.1161/01.cir.100.17.1816. [DOI] [PubMed] [Google Scholar]
- 22.Kaikita K, Soejima K, Matsukawa M, Nakagaki T, Ogawa H. Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction. J Thromb Haemost. 2006;4:2490–2493. doi: 10.1111/j.1538-7836.2006.02161.x. [DOI] [PubMed] [Google Scholar]
- 23.Crawley JT, Lane DA, Woodward M, Rumley A, Lowe GD. Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack. J Thromb Haemost. 2008;6:583–588. doi: 10.1111/j.1538-7836.2008.02902.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Zhao BQ, Chauhan AK, Canault M, Patten IS, Yang JJ, Dockal M, Scheiflinger F, Wagner DD. Von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke. Blood. 2009;114:3329–34. doi: 10.1182/blood-2009-03-213264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.de Maeyer B, De Meyer SF, Feys HB, Pareyn I, Vandeputte N, Deckmyn H, Vanhoorelbeke K. The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet-decorated VWF strings in vivo. J Thromb Haemost. 2010;8:2305–2312. doi: 10.1111/j.1538-7836.2010.04008.x. [DOI] [PubMed] [Google Scholar]
- 26.Laje P, Shang D, Cao W, Niiya M, Endo M, Radu A, Derogatis N, Scheiflinger F, Zoltick PW, Flake AW, Zheng XL. Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapy. Blood. 2009;113:2172–2180. doi: 10.1182/blood-2008-08-173021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Niiya M, Endo M, Shang D, Zoltick PW, Muvarak NE, Cao W, Jin SY, Skipwith CG, Motto DG, Flake AW, Zheng XL. Correction of ADAMTS13 deficiency by in utero gene transfer of lentiviral vector encoding ADAMTS13 genes. Mol Ther. 2009;17:34–41. doi: 10.1038/mt.2008.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Gandhi C, Khan MM, Lentz SR, Chauhan AK. ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice. Blood. 2011 doi: 10.1182/blood-2011-09-376202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Chauhan AK, Motto DG, Lamb CB, Bergmeier W, Dockal M, Plaimauer B, Scheiflinger F, Ginsburg D, Wagner DD. Systemic antithrombotic effects of ADAMTS13. J Exp Med. 2006;203:767–776. doi: 10.1084/jem.20051732. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Massberg S, Brand K, Gruner S, Page S, Muller E, Muller I, Bergmeier W, Richter T, Lorenz M, Konrad I, Nieswandt B, Gawaz M. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002;196:887–896. doi: 10.1084/jem.20012044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Methia N, Andre P, Denis CV, Economopoulos M, Wagner DD. Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood. 2001;98:14241428. doi: 10.1182/blood.v98.5.1424. [DOI] [PubMed] [Google Scholar]
- 32.Gandhi C, Khan MM, Lentz SR, Chauhan AK. ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice. Blood. 2011 doi: 10.1182/blood-2011-09-376202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Methia N, Andre P, Denis CV, Economopoulos M, Wagner DD. Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood. 2001;98:14241428. doi: 10.1182/blood.v98.5.1424. [DOI] [PubMed] [Google Scholar]
- 34.Massberg S, Brand K, Gruner S, Page S, Muller E, Muller I, Bergmeier W, Richter T, Lorenz M, Konrad I, Nieswandt B, Gawaz M. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002;196:887–896. doi: 10.1084/jem.20012044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Sperandio M, Smith ML, Forlow SB, Olson TS, Xia L, McEver RP, Ley K. P-selectin glycoprotein ligand-1 mediates L-selectin-dependent leukocyte rolling in venules. J Exp Med. 2003;197:1355–1363. doi: 10.1084/jem.20021854. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Pendu R, Terraube V, Christophe OD, Gahmberg CG, de Groot PG, Lenting PJ, Denis CV. P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor. Blood. 2006;108:3746–3752. doi: 10.1182/blood-2006-03-010322. [DOI] [PubMed] [Google Scholar]
- 37.Lewinsohn DM, Bargatze RF, Butcher EC. Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes. J Immunol. 1987;138:4313–4321. [PubMed] [Google Scholar]
- 38.Tedder TF, Steeber DA, Pizcueta P. L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites. J Exp Med. 1995;181:2259–2264. doi: 10.1084/jem.181.6.2259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Huo Y, Xia L. P-selectin glycoprotein ligand-1 plays a crucial role in the selective recruitment of leukocytes into the atherosclerotic arterial wall. Trends Cardiovasc Med. 2009;19:140–145. doi: 10.1016/j.tcm.2009.07.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.